AAAAI 2025 at a glance
As AAAAI 2025 approaches, LucidQuest highlights the key developments in allergy, asthma, immunology, and AI/ML to help you focus on the most relevant sessions.
📅 Build your schedule around the topics that interest you.
📥 Download the AAAAI 2025_Preview_by_LucidQuest
Dive deeper
Key Topics From AAAAI 2025 Scientific Presentations
Asthma & Respiratory Diseases
-
Dupilumab cuts exacerbations by 93% (RAPID).
-
Eos (≥150–500/µL) + FeNO (≥20) predict remission (QUEST).
-
EU-ADVANTAGE sees +16.5% lung function vs. other biologics. 🏹💨
Systemic Mastocytosis
-
Avapritinib, bezuclastinib, elenestinib thrive in ISM.
-
SUMMIT: bezuclastinib lowers tryptase (–94.4%) & mast cells (–92.3%), with 49.1% symptom gain.
-
JAK2 blockers may boost KIT inhibitor potency. 🏥🔬
Urticaria & Angioedema
-
Sebetralstat, navenibart redefine HAE.
-
Donidalorsen + garadacimab cut attacks 97%.
-
Remibrutinib + barzolvolimab sustain chronic urticaria control. 🦠💡
CRSwNP & Sinusitis
-
Depemokimab (2x/yr) lowers polyp scores.
-
Tezepelumab reduces surgery/steroids.
-
Dupilumab significantly boosts QoL in CRSwNP + AERD. 🌱⚕️
Food Allergy & Immunotherapy
-
Omalizumab beats OIT (36% vs. 19%) in multi-food allergy.
-
High-dose early peanut OIT fosters lasting tolerance (improved IgG4:IgE). 🍞💉
Atopic Dermatitis & Dermatology
-
IRL201104 is dose-responsive; tapinarof + ruxolitinib show broad efficacy.
-
Dupilumab normalizes amino acids, cuts pediatric AD inflammation. 🧴🩺
Pediatric Allergy
-
#Obesity raises allergic rhinitis risk (24%).
-
Stepwise egg OIT safe; VIASKIN peanut yields 73.3% response at 60 months (93% compliance). 🎈🌟
Immunology & Infection
-
Helminth coinfection may lessen severe COVID-19.
-
Dupilumab helps EoE regardless of diet.
-
Patch testing detects contact allergens in chronic ulcer care. 🌐🔬
Artificial Intelligence and Machine Learning at AAAAI 2025
AI in Environmental Health
-
Models fuse pollution/climate data to predict respiratory disease. 🤖📊
AI in Allergy & Asthma
-
ML refines allergen exposure, thunderstorm asthma, OIT education, and pollen tracking (94.7% accuracy). ⛅🌱
AI for Early Detection
-
EHR-based AI improves SM screening, oral food challenge forecasts, and tailored AR predictions. ⚙️🗂️
AI in Practice
-
Chatbots + predictive tools assist anaphylaxis response; performance gaps remain. 🚑🩺
AI for Equity & Fairness
-
Race-neutral AI lowers disparity in asthma hospitalizations, boosting care for underserved groups. 🤝⚖️
📅 Build your schedule around the topics that interest you.
📥 Download the AAAAI 2025_Preview_by_LucidQuest
Contact us for end-to-end conference coverage.